Endometriosis-associated ovarian cancer is a single entity with distinct clinicopathological characteristics

References

• Kumar S, Munkarah A, Arabi H, Bandyopadhyay S, Semaan A, Hayek K, Garg G, Morris R, Ali-Fehmi R. Prognostic analysis of ovarian cancer associated with endometriosis. Am J Obstet Gynecol. 2011;204:63.e1. doi:10.1016/j.ajog.2010.08.017.
   PubMed Web of Science ®Google Scholar
• Webb PM, Jordan SJ. Epidemiology of epithelial ovarian cancer. Best Pract Res Cl Ob. 2017;41:3. doi:10.1016/j.bpobgyn.2016.08.006.
   Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin. 2018;68:7–30. doi:10.3322/caac.21442.
   PubMed Web of Science ®Google Scholar
• Gorp TV, Amant F, Neven P, Vergote I, Moerman P. Endometriosis and the development of malignant tumours of the pelvis. A Review of Literature. Best Pract Res Cl Ob. 2004;18:349–371. doi:10.1016/j.bpobgyn.2003.03.001.
   PubMed Web of Science ®Google Scholar
• Vercellini P, Viganò P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10:261. doi:10.1038/nrendo.2013.255.
   PubMed Web of Science ®Google Scholar
• Somigliana E, Vigano’ P, Parazzini F, Stoppelli S, Giambattista E, Vercellini P. Association between endometriosis and cancer: a comprehensive review and a critical analysis of clinical and epidemiological evidence. Gynecol Oncol. 2006;101:331–341. doi:10.1016/j.ygyno.2005.11.033.
   PubMed Web of Science ®Google Scholar
• Nagle CM, Olsen CM, Webb PM, Jordan SJ, Whiteman DC, Green AC. Endometrioid and clear cell ovarian cancers: a comparative analysis of risk factors. Eur J Cancer. 2008;44:2477. doi:10.1016/j.ejca.2008.07.009.
   PubMed Web of Science ®Google Scholar
• Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, Nagle CM, Doherty JA, Cushing-Haugen KL, Wicklund KG. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol. 2012;13:385–394. doi:10.1016/S1470-2045(11)70404-1.
   PubMed Web of Science ®Google Scholar
• Moll UM, Chumas JC, Chalas E, Mann WJ. Ovarian carcinoma arising in atypical endometriosis. Obstet Gynecol. 1990;75:537–539.
   PubMed Web of Science ®Google Scholar
• Siufi NJ, Kho RM, Siufi DF, Baracat EC, Anderson KS, Abrão MS. Cellular, histologic, and molecular changes associated with endometriosis and ovarian cancer. J Minim Invasive Gynecol. 2014;21:55–63. doi:10.1016/j.jmig.2013.07.021.
   PubMed Web of Science ®Google Scholar
• Pavone ME, Lyttle BM. Endometriosis and ovarian cancer: links, risks, and challenges faced. Int J Womens Health. 2015;7:663–672. doi:10.2147/IJWH.S66824.
   PubMed Web of Science ®Google Scholar
• Krawczyk N, Banys-Paluchowski M, Schmidt D, Ulrich U, Fehm T. Endometriosis-associated Malignancy. Geburtshilfe Frauenheilkd. 2016;76:176. doi:10.1055/s-0035-1558239.
   PubMed Web of Science ®Google Scholar
• Farfaras A, Danielis M, Papavasileiou S, Barbounaki S, Bilirakis E, Skolarikos P. Insight into the mechanisms of endometriosis associated ovarian cancers development. Cancer Res Front. 2016;2:112–125. doi:10.17980/2015.1.
   Google Scholar
• Scarfone G, Bergamini A, Noli S, Villa A, Cipriani S, Taccagni G, Vigano’ P, Candiani M, Parazzini F, Mangili G. Characteristics of clear cell ovarian cancer arising from endometriosis: a two center cohort study. Gynecol Oncol. 2014;133:480. doi:10.1016/j.ygyno.2014.03.017.
   PubMed Web of Science ®Google Scholar
• Kim HS, Chung HH, Kim JW, Park NH, Song YS. ISO–4–1 Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis(group 4 oncology 2,IS Award Candidate,International Session). J Bacteriol. 2001;182:6975–6982.
   Google Scholar
• Depriest PD, Banks ER, Powell DE, Jr JRVN, Gallion HH, Puls LE, Hunter JE, Kryscio RJ, Royalty MB. Endometrioid carcinoma of the ovary and endometriosis: the association in postmenopausal women. Gynecol Oncol. 1992;47:71–75.
   PubMed Web of Science ®Google Scholar
• Sampson JA. Endometrial carcinoma of the ovary arising in endometrial tissue in that organ. Am J Obstet Gynecol. 1925;9:111–114. doi:10.1016/S0002-9378(25)90949-0.
   Google Scholar
• Scott RB. Malignant changes in endometriosis. Obstet Gynecol. 1953;2:283.
   PubMed Web of Science ®Google Scholar
• Kurman RJ, Ie-Ming S. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer–shifting the paradigm. Hum Pathol. 2011;42:918–931. doi:10.1016/j.humpath.2011.03.003.
   PubMed Web of Science ®Google Scholar
• Jones S, Wang TL, Iem S, Mao TL, Nakayama K, Roden R, Glas R, Slamon D, Jr DL, Vogelstein B. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science. 2010;330:228. doi:10.1126/science.1196333.
   PubMed Web of Science ®Google Scholar
• Wiegand KC, Shah SP, Al-Agha OM, Zhao Y, Tse K, Zeng T, Senz J, McConechy MK, Anglesio MS, Kalloger SE, et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med. 2010;363:1532–1543. doi:10.1056/NEJMoa1008433.
   PubMed Web of Science ®Google Scholar
• Kim HS, Kim TH, Chung HH, Song YS. Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis. Br J Cancer. 2014;110:1878–1890. doi:10.1038/bjc.2014.29.
   PubMed Web of Science ®Google Scholar
• Mangili G, Bergamini A, Taccagni G, Gentile C, Panina P, Viganò P, Candiani M. Unraveling the two entities of endometrioid ovarian cancer: A single center clinical experience. Gynecol Oncol. 2012;126:403–407. doi:10.1016/j.ygyno.2012.05.007.
   PubMed Web of Science ®Google Scholar
• Nnoaham KE, Premila W, Jharna K, Kennedy SH, Zondervan KT. Is early age at menarche a risk factor for endometriosis? A systematic review and meta-analysis of case-control studies. Fertil Steril. 2012;98:702–712. doi:10.1016/j.fertnstert.2012.05.035.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Sumimoto K, Moniwa N, Imai M, Takakura K, Kuromaki T, Morioka E, Arisawa K, Terao T. Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan. Int J Gynecol Cancer. 2007;17:37–43. doi:10.1111/j.1525-1438.2006.00754.x.
   PubMed Web of Science ®Google Scholar
• Brinton LA, Lamb EJ, Moghissi KS, Scoccia B, Althuis MD, Mabie JE, Westhoff CL. Ovarian cancer risk associated with varying causes of infertility. Fertil Steril. 2004;82:405–414. doi:10.1016/j.fertnstert.2004.02.109.
   PubMed Web of Science ®Google Scholar
• Stewart LM, Holman CD, Aboagyesarfo P, Finn JC, Preen DB, Hart R. In vitro fertilization, endometriosis, nulliparity and ovarian cancer risk. Gynecol Oncol. 2013;128:260–264. doi:10.1016/j.ygyno.2012.10.023.
   PubMed Web of Science ®Google Scholar
• Komiyama SI, Aoki D, Tominaga E, Susumu N, Udagawa Y, Nozawa S. Prognosis of Japanese patients with ovarian clear cell carcinoma associated with pelvic endometriosis: clinicopathologic evaluation. Gynecol Oncol. 1999;72:342–346.
   PubMed Web of Science ®Google Scholar
• Davis M, Rauh-Hain JA, Andrade C, Ii DMB, Schorge JO, Horowitz NS, May T, Carmen MGD. Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary. Gynecol Oncol. 2014;132:760–766.
   PubMed Web of Science ®Google Scholar
• Wang S, Qiu L, Lang JH, Shen K, Yang JX, Huang HF, Pan LY, Wu M. Clinical analysis of ovarian epithelial carcinoma with coexisting pelvic endometriosis. Am J Obstet Gynecol. 2013;208:413.e1. doi:10.1016/j.ajog.2012.12.004.
   Web of Science ®Google Scholar
• Lim MC, Lee DO, Kang S, Seo SS, Lee BY, Park SY. Clinical manifestations in patients with ovarian clear cell carcinoma with or without co-existing endometriosis. Gynecol Endocrinol. 2009;25:435–440. doi:10.1080/09513590902770131.
   PubMed Web of Science ®Google Scholar
• Andersen MR, Goff BA, Lowe KA, Scholler N, Bergan L, Drescher CW, Paley P, Urban N. Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer. Gynecol Oncol. 2010;116:378. doi:10.1016/j.ygyno.2009.10.087.
   PubMed Web of Science ®Google Scholar
• Drapkin R, Horsten HHV, Lin Y, Mok SC, Crum CP, Welch WR, Hecht JL. Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Res. 2005;65:2162–2169. doi:10.1158/0008-5472.CAN-04-3924.
   PubMed Web of Science ®Google Scholar
• Ma CLK. Figo stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Semin Surg Oncol. 2010;10:31–46.
   Google Scholar
• Magazzino F, Katsaros D, Ottaiano A, Gadducci A, Pisano C, Sorio R, Rabaiotti E, Scambia G, Cormio G, Scarampi L. Surgical and medical treatment of clear cell ovarian cancer: results from the Multicenter Italian Trials in Ovarian Cancer (MITO) 9 retrospective study. J Hepatol. 2011;56:567.
   Google Scholar
• Itamochi H, Kigawa J, Terakawa N. Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma. Cancer Sci. 2008;99:653. doi:10.1111/j.1349-7006.2008.00747.x.
   PubMed Web of Science ®Google Scholar
• Fuseya C, Horiuchi A, Hayashi A, Suzuki A, Miyamoto T, Hayashi T, Shiozawa T. Involvement of pelvic inflammation-related mismatch repair abnormalities and microsatellite instability in the malignant transformation of ovarian endometriosis. Hum Pathol. 2012;43:1964–1972. doi:10.1016/j.humpath.2012.02.005.
   PubMed Web of Science ®Google Scholar
• Ren F, Wang D, Jiang Y, Ren F. Epigenetic inactivation of hMLH1 in the malignant transformation of ovarian endometriosis. Arch Gynecol Obstet. 2012;285:215–221. doi:10.1007/s00404-011-1922-x.
   PubMed Web of Science ®Google Scholar
• Jr WM, Liu S, Hua Y, Kwok JS, Samuel A, Hou L, Shoni M, Lu S, Sandberg EM, Keryan A. Molecular changes in endometriosis-associated ovarian clear cell carcinoma. Eur J Cancer. 2015;51:1831–1842. doi:10.1016/j.ejca.2015.05.011.
   PubMed Web of Science ®Google Scholar